- Scheme Category:
- Equity Scheme >
- Sectoral/Thematic Funds
NAV: ₹ ↓ -0.15%
NAV chart
SMA (Simple Moving Average)
- 50 SMA
- 100 SMA
- 200 SMA
- 400 SMA
Returns
CAGR returns till date
CAGR returns of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth and its peers as on 11 September, 2026| Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
|---|---|---|---|---|---|---|---|---|---|---|
| Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth | 19.3% | -0.15% | -0.27% | -1.32% | 9.05% | 17.47% | 21.79% | 14.44% | 21.43% | - |
| SBI CONSUMPTION OPPORTUNITIES FUND - DIRECT PLAN - GROWTH | -9.55% | -0.61% | -1.77% | -6.48% | 0.55% | -13.4% | 4.69% | 12.12% | 15.55% | 13.48% |
| SBI ESG Exclusionary Strategy Fund - Direct Plan -Growth | -5.09% | -0.49% | -2.13% | -4.09% | 3.04% | -1.59% | 8.1% | 8.16% | 13.27% | 11.45% |
| SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH | 25.1% | -0.28% | 0.76% | -0.34% | 11.62% | 21.41% | 24.25% | 18.68% | 25.98% | 14.82% |
| SBI INFRASTRUCTURE FUND - DIRECT PLAN - GROWTH | 0.9% | -0.52% | -0.99% | -2.51% | 2.23% | 4.49% | 13.03% | 16.01% | 19.85% | 15.13% |
| SBI COMMA Fund - DIRECT PLAN - Growth | 6.56% | -1.27% | -2.15% | -0.7% | 4.16% | 12.2% | 15.12% | 11.14% | 20.13% | 15.56% |
Discrete returns (yearly)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | - | - | - | - | 57.54% | 20.14% | -11.24% | 40.42% | 37.69% | -3.36% |
Discrete returns (monthly)
| Month | Nov 2025 | Dec 2025 | Jan 2026 | Feb 2026 | Mar 2026 | Apr 2026 | May 2026 | Jun 2026 | Jul 2026 | Aug 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | 0.44% | -1.25% | -3.8% | 4.81% | -3.21% | 5.19% | 3.93% | 6.31% | 5.11% | 1.75% |
Returns from spefic dates
| Description | CAGR returns from 18 Oct 2021 (Nifty 50 2021 high) | CAGR returns from 26 Sep 2024 (Nifty 50 2024 high) |
|---|---|---|
| Returns | 14.78% | 7.69% |
Portfolio
Asset allocation
| Equity | Debt | Realestate | Commodities | Cash & Equivalents |
|---|---|---|---|---|
| 97.61% | 0.00% (Arbitrage: 0.00%) | 0.00% | 0.00% | 2.39% |
Equity
| Name | Symbol / ISIN | Sector | Weight % | Other links |
|---|---|---|---|---|
| Torrent Pharmaceuticals Ltd. | TORNTPHARM (INE685A01028) | Pharmaceuticals & Biotechnology | 9.94% | |
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA (INE044A01036) | Pharmaceuticals & Biotechnology | 9.75% | |
| Apollo Hospitals Enterprise Ltd. | APOLLOHOSP (INE437A01024) | Healthcare Services | 7.08% | |
| Cipla Ltd. | CIPLA (INE059A01026) | Pharmaceuticals & Biotechnology | 4.56% | |
| Aurobindo Pharma Ltd. | AUROPHARMA (INE406A01037) | Pharmaceuticals & Biotechnology | 4.29% | |
| Ajanta Pharma Ltd. | AJANTPHARM (INE031B01049) | Pharmaceuticals & Biotechnology | 4.17% | |
| Sai Life Sciences Ltd. | SAILIFE (INE570L01029) | Pharmaceuticals & Biotechnology | 3.89% | |
| Mankind Pharma Ltd. | MANKIND (INE634S01028) | Pharmaceuticals & Biotechnology | 3.58% | |
| Lupin Ltd. | LUPIN (INE326A01037) | Pharmaceuticals & Biotechnology | 3.51% | |
| Abbott India Ltd. | ABBOTINDIA (INE358A01014) | Pharmaceuticals & Biotechnology | 3.35% | |
| Emcure Pharmaceuticals Ltd. | EMCURE (INE168P01015) | Pharmaceuticals & Biotechnology | 3.24% | |
| Fortis Healthcare Ltd. | FORTIS (INE061F01013) | Healthcare Services | 2.98% | |
| IPCA Laboratories Ltd. | IPCALAB (INE571A01038) | Pharmaceuticals & Biotechnology | 2.47% | |
| Gland Pharma Ltd. | GLAND (INE068V01023) | Pharmaceuticals & Biotechnology | 2.34% | |
| Shilpa Medicare Ltd. | SHILPAMED (INE790G01031) | Pharmaceuticals & Biotechnology | 2.32% | |
| Corona Remedies Ltd. | CORONA (INE02ZQ01018) | Pharmaceuticals & Biotechnology | 2.29% | |
| Procter & Gamble Health Ltd. | PGHL (INE199A01012) | Pharmaceuticals & Biotechnology | 2.16% | |
| Dr. Lal Path labs Ltd. | LALPATHLAB (INE600L01024) | Healthcare Services | 2.12% | |
| Jupiter Life Line Hospitals Ltd. | (INE682M01020) | Healthcare Services | 2.03% | |
| Divi's Laboratories Ltd. | DIVISLAB (INE361B01024) | Pharmaceuticals & Biotechnology | 1.95% | |
| Thyrocare Technologies Ltd. | THYROCARE (INE594H01019) | Healthcare Services | 1.91% | |
| Alkem Laboratories Ltd. | ALKEM (INE540L01014) | Pharmaceuticals & Biotechnology | 1.88% | |
| Metropolis Healthcare Ltd. | METROPOLIS (INE112L01020) | Healthcare Services | 1.59% | |
| Sanofi Consumer Healthcare India Ltd. | SANOFICONR (INE0UOS01011) | Pharmaceuticals & Biotechnology | 1.36% | |
| Pfizer Ltd. | PFIZER (INE182A01018) | Pharmaceuticals & Biotechnology | 1.26% | |
| Biocon Ltd. | BIOCON (INE376G01013) | Pharmaceuticals & Biotechnology | 1.26% | |
| Piramal Pharma Ltd. | PPLPHARMA (INE0DK501011) | Pharmaceuticals & Biotechnology | 1.16% | |
| Anthem Biosciences Ltd. | ANTHEM (INE0CZ201020) | Pharmaceuticals & Biotechnology | 1.07% | |
| Dr. Reddy's Laboratories Ltd. | DRREDDY (INE089A01031) | Pharmaceuticals & Biotechnology | 1.06% | |
| Vijaya Diagnostic Centre Ltd. | VIJAYA (INE043W01024) | Healthcare Services | 0.98% | |
| Manipal Health Enterprises Ltd A** | (INE459N01021) | Healthcare Services | 0.89% | |
| Medi Assist Healthcare Services Ltd. | MEDIASSIST (INE456Z01021) | Insurance | 0.87% | |
| Glaxosmithkline Pharmaceuticals Ltd. | GLAXO (INE159A01016) | Pharmaceuticals & Biotechnology | 0.80% | |
| Suraksha Diagnostic Ltd. | SURAKSHA (INE877V01027) | Healthcare Services | 0.79% | |
| Vinati Organics Ltd. | VINATIORGA (INE410B01037) | Chemicals & Petrochemicals | 0.78% | |
| Max Healthcare Institute Ltd. | MAXHEALTH (INE027H01010) | Healthcare Services | 0.72% | |
| Syngene International Ltd. | SYNGENE (INE398R01022) | Healthcare Services | 0.68% | |
| Jubilant Pharmova Ltd. | JUBLPHARMA (INE700A01033) | Pharmaceuticals & Biotechnology | 0.55% |
Portfolio data is as on date 31 July, 2026
NAV history
Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth - 30 days NAV (Net asset value) history
| Date | NAV | % change |
|---|---|---|
| 11 September, 2026 | 40.48 | -0.15% |
| 10 September, 2026 | 40.54 | -0.69% |
| 9 September, 2026 | 40.82 | -0.15% |
| 8 September, 2026 | 40.88 | 0.44% |
| 7 September, 2026 | 40.70 | 0.27% |
| 4 September, 2026 | 40.59 | -0.49% |
| 3 September, 2026 | 40.79 | -0.12% |
| 2 September, 2026 | 40.84 | -0.02% |
| 1 September, 2026 | 40.85 | -0.92% |
| 31 August, 2026 | 41.23 | 0.54% |
| 28 August, 2026 | 41.01 | 0.12% |
| 27 August, 2026 | 40.96 | 0.52% |
| 26 August, 2026 | 40.75 | 0.1% |
| 25 August, 2026 | 40.71 | 0.32% |
| 24 August, 2026 | 40.58 | 0% |
| 21 August, 2026 | 40.58 | -0.29% |
| 20 August, 2026 | 40.70 | 0% |
| 19 August, 2026 | 40.70 | -0.15% |
| 18 August, 2026 | 40.76 | 0.27% |
| 17 August, 2026 | 40.65 | -0.47% |
| 14 August, 2026 | 40.84 | -0.27% |
| 13 August, 2026 | 40.95 | 0% |
| 12 August, 2026 | 40.95 | -0.17% |
| 11 August, 2026 | 41.02 | 0.44% |
| 10 August, 2026 | 40.84 | 0.29% |
| 7 August, 2026 | 40.72 | 0.22% |
| 6 August, 2026 | 40.63 | -0.1% |
| 5 August, 2026 | 40.67 | 0.17% |
| 4 August, 2026 | 40.60 | 0.22% |
| 3 August, 2026 | 40.51 |
FAQ (Frequently asked questions)
What is latest/current NAV/price of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth?
The latest NAV of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth is 40.48 as on 11 September, 2026.What are YTD (year to date) returns of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth?
The YTD (year to date) returns of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth are 19.3% as on 11 September, 2026.What are 1 year returns of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth?
The 1 year returns of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth are 17.47% as on 11 September, 2026.What are 3 year CAGR returns of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth?
The 3 year annualized returns (CAGR) of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth are 21.79% as on 11 September, 2026.What are 5 year CAGR returns of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth?
The 5 year annualized returns (CAGR) of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth are 14.44% as on 11 September, 2026.What is LTCG (Long term capital gain) and STCG (Short term capital gain) tax for Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth?
Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth is equity oriented mutual fund. Various capital gain taxes are applicable as below (Effective for redemption after July 23, 2024 and from FY 2024-25)Holding period Tax rate Less than 1 year (STCG) 20% More than 1 year (LTCG) Tax free upto Rs. 1.25 lakhs. 12.5% on rest amount.